Skip to main content
. Author manuscript; available in PMC: 2014 Jun 3.
Published in final edited form as: J Natl Compr Canc Netw. 2013 May 1;11(5):594–615. doi: 10.6004/jnccn.2013.0075

Table 1.

Individual Disclosures for the NCCN Penile Cancer Panel

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed
Neeraj Agarwal, MD None None None None 8/3/12
Matthew C. Biagioli, MD, MS None None None None 10/16/12
Peter E. Clark, MD None Archimedes Pharma Ltd. None None 8/28/12
Mario A. Eisenberger, MD Bristol-Myers Squibb Company; Genentech, Inc.; Agensys, Inc.; and sanofi-aventis U.S. LLC Ipsen None None 8/31/12
Richard E. Greenberg, MD None Endo Pharmaceuticals Inc. None None 3/26/13
Harry W. Herr, MD None None None None 8/28/12
Brant A. Inman, MD, MSc GlaxoSmithKline plc None None None 8/28/12
Deborah A. Kuban, MD None None Immtech International, Inc. None 8/28/12
Timothy M. Kuzel, MD Bayer AG; Bristol-Myers Squibb Company; CureTech; Eli Lilly and Company; GlaxoSmithKline; Merck & Co., Inc.; Novartis AG; Onyx Pharmaceuticals, Inc.; Alton Pharma, Inc.; Argos Therapeutics, Inc.; and Biovex Group, Inc. Celgene Corporation; Exelixis Inc.; Genentech, Inc.; GlaxoSmithKline plc; Jannsen Pharmaceuticals, Inc.; Novartis AG; Onyx Pharmaceuticals, Inc.; Affymax, Inc.; AVEO Pharmaceuticals, Inc.; and Prometheus Laboratories Inc. None None 8/28/12
Subodh M. Lele, MD None None None None 8/28/12
Jeff Michalski, MD, MBA None None None None 8/13/12
Lance C. Pagliaro, MD None None None None 1/4/13
Sumanta K. Pal, MD None Genentech, Inc.; GlaxoSmithKline plc; Novartis AG; Pfizer Inc.; and sanofi-aventis U.S. LLC None None 3/27/12
Anthony Patterson, MD None None None None 8/15/12
Elizabeth R. Plimack, MD, MS None Amgen Inc. None None 10/17/12
Kamal S. Pohar, MD None None None None 9/27/12
Michael P. Porter, MD, MS None None None None 4/25/12
Jerome P. Richie, MD None None None None 5/2/12
Wade J. Sexton, MD Endo Pharmaceuticals Inc. Endo Pharmaceuticals None None 8/3/12
William U. Shipley, MD None None Pfizer Inc. None 8/28/12
Eric J. Small, MD None Dendreon Corporation None None 9/24/12
Philippe E. Spiess, MD, MS None None None None 5/4/12
Donald L. Trump, MD None None None None 5/17/12
Geoffrey Wile, MD None None None None 6/13/12
Timothy G. Wilson, MD None Covidien None None 1/6/12

The NCCN guidelines staff have no conflicts to disclose.